Not recruiting
Colorectal cancer metastatic
Not recruitingStudy of Galunisertib and Capecitabine for Patients with Advanced Chemotherapy-Resistant Colorectal Cancer with Peritoneal Metastases
Registered drugNo placebo
Study of Galunisertib and Capecitabine for Patients with Advanced Chemotherapy-Resistant Colorectal Cancer with Peritoneal Metastases
Registered drugNo placebo
- Disease:Colorectal cancer metastatic
- Substances:CapecitabineGalunisertib
Countries:
The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Capecitabine
